A study to characterize the pharmacokinetic profile of norucholic acid (NCA) in patients with primary sclerosing cholangitis (PSC)

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507027-37-00

Acronym

NUC-011/BIO

Enrollment

Registered

2023-12-01

Start date

2023-07-20

Completion date

2024-11-29

Last updated

2024-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Sclerosing Cholangitis (PSC)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria, Finland, Germany, Norway

None listed

Source: EU CTIS · Data processed: Feb 4, 2026